- Home
- FUSB vs BEAT Comparison
FUSB vs BEAT Comparison
Compare FUSB & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- BEAT
- Stock Information
- Founded
- FUSB 1952
- BEAT 2015
- Country
- FUSB United States
- BEAT United States
- Employees
- FUSB N/A
- BEAT N/A
- Industry
- FUSB Major Banks
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- FUSB Finance
- BEAT Technology
- Exchange
- FUSB Nasdaq
- BEAT Nasdaq
- Market Cap
- FUSB 73.3M
- BEAT 74.1M
- IPO Year
- FUSB N/A
- BEAT 2021
- Fundamental
- Price
- FUSB $12.50
- BEAT $2.31
- Analyst Decision
- FUSB
- BEAT Buy
- Analyst Count
- FUSB 0
- BEAT 1
- Target Price
- FUSB N/A
- BEAT $8.00
- AVG Volume (30 Days)
- FUSB 1.8K
- BEAT 110.4K
- Earning Date
- FUSB 01-27-2025
- BEAT 03-19-2025
- Dividend Yield
- FUSB 2.27%
- BEAT N/A
- EPS Growth
- FUSB 0.00
- BEAT N/A
- EPS
- FUSB 1.33
- BEAT N/A
- Revenue
- FUSB $39,110,000.00
- BEAT N/A
- Revenue This Year
- FUSB N/A
- BEAT N/A
- Revenue Next Year
- FUSB N/A
- BEAT N/A
- P/E Ratio
- FUSB $9.29
- BEAT N/A
- Revenue Growth
- FUSB N/A
- BEAT N/A
- 52 Week Low
- FUSB $8.66
- BEAT $1.35
- 52 Week High
- FUSB $14.30
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- FUSB 48.06
- BEAT 51.07
- Support Level
- FUSB $12.25
- BEAT $2.19
- Resistance Level
- FUSB $12.80
- BEAT $2.41
- Average True Range (ATR)
- FUSB 0.29
- BEAT 0.14
- MACD
- FUSB -0.01
- BEAT 0.04
- Stochastic Oscillator
- FUSB 33.71
- BEAT 66.67
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.